AU2007292816B2 — Benzo-fused compounds for use in treating metabolic disorders
Assigned to Amgen Inc · Expires 2011-11-17 · 15y expired
What this patent protects
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L, ℗, L, M, X, L, and A are provided herein. The present invention also provides compo…
USPTO Abstract
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L, ℗, L, M, X, L, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
Drugs covered by this patent
- Zurampic (LESINURAD) · Ironwood Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.